S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
ASX:PME

Pro Medicus (PME) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
285,954 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
0.35%
Price Target
N/A
PME stock logo

About Pro Medicus Stock (ASX:PME)

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

PME Stock News Headlines

The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Pro Medicus Limited (PME.XA)
Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Pro Medicus Ltd (PME)
Could Core Lithium be a millionaire-maker stock?
Visage Soars with CloudPACS at RSNA 2023
See More Headlines
Receive PME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro Medicus and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/21 Dividend
2/28/2024
Dividend Payable
3/21/2024
Today
4/17/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
2,060
Year Founded
N/A

Profitability

Net Income
$69.71 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$142.12 million
Book Value
A$1.52 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.52
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Dr. Sam Aaron Hupert M.B.B.S.
    M.D., Co-Founder, CEO, MD & Executive Director
  • Mr. Anthony Barry Hall B.Sc.
    B.Sc.(Hons), M.Sc., Co-Founder, Technology Director & Executive Director
  • Mr. Clayton James Hatch B.Comm
    CPA, CPA, Chief Financial Officer
  • Dr. Malte Westerhoff
    GM of Europe & Global CTO
  • Mr. Brad Levin
    GM of North America & Global Head of Marketing
  • Ms. Sharni L. Redenbach
    People & Culture Director
  • Mr. Sean Lambright
    Global Head of Sales - Visage Imaging Inc
  • Ms. Teresa Gschwind
    Global Head of Customer Service of Visage Imaging Inc.
  • Ms. Danny English C.A.
    Financial Controller & Company Secretary

PME Stock Analysis - Frequently Asked Questions

How often does Pro Medicus pay dividends? What is the dividend yield for Pro Medicus?

Pro Medicus announced a Interim dividend on Thursday, February 22nd. Shareholders of record on Thursday, March 21st will be given a dividend of 0.18 per share on Thursday, March 21st. This represents a yield of 0.19%. The ex-dividend date is Wednesday, February 28th. This is a boost from the stock's previous Interim dividend of A$0.13.
Read our dividend analysis for PME
.

Is Pro Medicus a good dividend stock?

Pro Medicus (ASX:PME) pays an annual dividend of A$0.36 per share and currently has a dividend yield of 0.35%. The dividend payout ratio is 54.55%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for PME.

What other stocks do shareholders of Pro Medicus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro Medicus investors own include ImmuPharma (IMM), Blackmores (BKL), Bank of America (BAC), Boeing (BA), Accent Group (AX1), Axos Financial (AX), ARB (ARB), Appen (APX), Arista Networks (ANET) and Altium (ALU).

This page (ASX:PME) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners